Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 6Terminated 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Lymphoma 9Lymphoma, Large B-Cell, Diffuse 7Leukemia, Myeloid, Acute 7Leukemia 6Multiple Myeloma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Hodgkin Disease 4Myelodysplastic Syndromes 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Burkitt Lymphoma 3Sarcoma 2Retinoblastoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Central Nervous System Neoplasms 2Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1Solid Tumors 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Recurrence 1Primary Myelofibrosis 1Polycythemia Vera 1

Interventions

Temozolomide 3Magnetic Resonance Spectroscopy 3Radiotherapy 2Radiation 2Carmustine 2Carboplatin 2pazopanib 1gallium Ga 68 dotatate 1ficlatuzumab 1cabazitaxel 1Triiodothyronine 1TIC10 compound 1Sunitinib 1Sorafenib 1Procarbazine 1O(6)-benzylguanine 1Nivolumab 1Methimazole 1Magnetic Resonance Imaging 1Lomustine 1Isotretinoin 1Irinotecan 1Gadolinium DTPA 1Filgrastim 1Biopsy 1Axitinib 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Gliosarcoma × Filgrastim × Clear all
NCT00006263 2015-08-05

Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma

NYU Langone Health

Phase 2 Withdrawn
CNSSarcoma

Astrocytoma, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡